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Abstract
Introduction: Bone marrow lesions (BMLs) are features detected on MRI that are important in the pathogenesis of
knee osteoarthritis. Since BMLs reflect heterogeneous pathologies this prospective cohort study examined whether
BMLs detected using different MRI sequences are associated with distinct structural and clinical endpoints.
Methods: A total of 297 community-based adults without knee pain were examined to identify BMLs visualised
using three-dimensional T1-weighted gradient-echo fat-suppressed (T1-weighted sequences) fat-suppressed and
fat-saturated FSE T2-weighted MRI sequences (T2-weighted sequences) at baseline. Cartilage volume was measured
at baseline and follow-up, while incident knee pain was assessed at follow-up, an average of 2.3 years later.
Results: At baseline, 46 BMLs were visualised in 39 participants. Of the 45 BMLs visualised on T2-weighted sequences,
34 (74 %) were also seen on T1-weighted sequences. One BML was seen on only T1-weighted sequences. Knees with
BMLs visualised on both T1- and T2-weighted sequences had significantly higher medial tibial cartilage volume loss
(45 mm3/annum, standard error of the mean (SEM) 14) than those with BMLs identified on only T2-weighted sequences
(−13 mm3/annum SEM 19), after adjustment for age, gender and body mass index (p = 0.01). Incident knee pain was
more likely in individuals with BMLs in the medial compartment visualised on both T1- and T2-weighted (eight
participants, 53 %) compared to those with BMLs on only T2-weighted sequences (0 %) or no BMLs (76 participants,
31 %, p = 0.02).
Conclusions: BMLs present on both T1- and T2-weighted MRI sequences were associated with increased medial tibial
cartilage loss and incident knee pain compared with those BMLs seen only on T2-weighted sequences. This suggests
that combining different MRI sequences may provide more informative targets in the prevention and treatment of knee
osteoarthritis.
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Introduction
Bone marrow lesions (BMLs) are important in the patho-
genesis of knee osteoarthritis (OA). Both in those with and
without symptomatic knee OA, their presence has been
linked to knee pain [1, 2], increased cartilage volume loss
[3, 4], radiographic progression [5] and joint replacement
[6, 7]. BMLs are ill-defined hyperintensities on magnetic
resonance imaging (MRI), and have been described using a
variety of different sequences, including short inversion
time inversion recovery (STIR) images, T2-weighted, fat-
suppressed sequence and T1-weighted sequence [7, 8].
Although each of the different MRI sequences captures
different tissue properties [9], BMLs have been consid-
ered a homogeneous group in epidemiological studies.
Utilising different MRI sequences to characterise BMLs
may offer new insights into the composition and clinical
characteristics of BMLs.
The underlying pathology of BMLs has not been well
characterised. Bone within BMLs identified using T2-
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weighted fat-suppressed images was shown to be sclerotic
but less well mineralised than adjacent unaffected bone
[10]. In another study, BMLs identified by images obtained
using STIR, T1- and T2-weighted sequences showed that
affected tissue, rather than being oedematous, as was ini-
tially proposed [5], consisted of bone necrosis, fibrosis and
bone marrow necrosis, with little oedema [9]. In that study
of 16 patients with OA, Zanetti et al. began to differentiate
the underlying histology of BMLs visualised by differing
combinations of STIR, T1- and T2-weighted sequences.
At the lumbar spine, use of data obtained using two
different sequences has been shown to better discriminate
distinct vertebral body marrow and endplate lesions
(Modic change) [11], each with characteristic histological
and clinical correlates [11–20].
Whether BMLs at the knee identified using different
sequences have similar clinical correlates is not clear. How-
ever, while T2-weighted hyperintensities may be able to
identify more BMLs [21–23] compared to T1-weighted se-
quences, BMLs identified from either T1- or T2-weighted
images predict joint replacement surgery among people
with knee OA [6, 24]. Importantly, whether BMLs identi-
fied by different MRI sequences are differentially related to
clinically relevant outcomes such as cartilage loss and the
development of pain has not been examined.
To do so, we examined the prevalence of BMLs identi-
fied in the knees of asymptomatic adults using both T1-
(three-dimensional T1-weighted spoiled gradient echo
(SPGR) fat-suppressed) and T2-weighted (T2-weighted fat-
saturated) sequences. We investigated whether BMLs iden-
tified from these T1-, T2- or both T1- and T2-weighted
images related differentially to the rate of cartilage volume




The study was conducted within the Melbourne Collab-
orative Cohort Study (MCCS), a prospective cohort study
of 41,514 people, as described previously [25]. We invited
subjects who attended the first year of the second follow-
up of the MCCS (2003–2004), provided they were aged
between 50 and 79 years and did not meet a clinical
diagnosis of knee OA as defined by American College of
Rheumatology criteria [26]. Participants were excluded if
they indicated a history of knee pain lasting for > 24 hours
in the last 5 years; a previous knee injury requiring non-
weight-bearing treatment for > 24 hours or surgery (in-
cluding arthroscopy); a history of any arthritis diagnosed
by a medical practitioner; or any contraindication to MRI.
Quota sampling was used, whereby recruitment ceased
when our target of approximately 300 subjects was
reached. A follow-up MRI was performed between 2006
and 2007, with an average of 2.3 years having elapsed since
the initial imaging study. The study was approved by the
Human Research Ethics Committees of The Cancer
Council Victoria and Monash University. All participants
gave written informed consent.
Anthropometric measures
Height (cm) was measured at baseline using a stadiometer
with footwear removed. Weight (kg) was measured with
bulky clothing removed at the time of baseline MRI. Body
mass index (BMI) was calculated from these data [weight
(kg)/height2 (m2)].
MRI image acquisition
In 2003–2004 and again in 2006–2007, the dominant knee
(defined as the lower limb the subject used to kick a ball)
of each subject was imaged using MRI. At each visit,
knees were imaged on a 1.5-T whole body magnetic
resonance unit (Philips 1.5 Tesla Intera; Philips Medical
Systems, Eindhoven, The Netherlands) using a commercial
transmit-receive extremity coil. The following sequences
and parameters were used: a T1-weighted fat-suppressed
three-dimensional gradient recall acquisition in the steady
state; flip angle 55 degrees; repetition time 58 msec; echo
time 12 msec; field of view 16 cm; 60 partitions; 512 × 512
matrix; one acquisition time 11 minutes 56 seconds.
Sagittal images were obtained at a partition thickness
of 1.5 mm and an in-plate resolution of 0.31 × 0.31 mm
(512 × 512 pixels). These sequences will be referred to as
T1-weighted sequences hereafter throughout the manu-
script. In addition, a coronal T2-weighted fat-saturated
acquisition (T2-weighted fat-saturated), repetition time
3500–3800 msec, echo time 50 msec, with a slice thick-
ness of 3.0 mm, a 1.0 mm interslice gap, 1 excitation, a
field of view of 13 cm, and a matrix of 256 × 192 was also
obtained [27]. The acquisition time for the T2-weighted
fat-saturated sequence was 4 minutes 46 seconds. The
echo train length was 7. These sequences will be referred
to as T2-weighted sequences throughout the manuscript.
All MRI images were read by a clinical radiologist with
musculoskeletal MRI expertise to identify the presence
of any clinically significant abnormalities.
MRI related measures
BMLs were defined as areas of increased signal intensity
immediately underlying subchondral bone in either the
medial or lateral distal femur or proximal tibia in either
imaging sequences [24, 28]. Two trained observers, who
were blinded to patient characteristics, as well as image
sequence, together assessed the presence of BMLs for each
subject. The presence or absence of BMLs was determined.
Figure 1 demonstrates two BMLs seen using both se-
quences. The reproducibility for the presence of BMLs was
assessed using 60 randomly selected knee MRIs (к value
0.88, p < 0.001) [29].
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Cartilage volume was determined by image processing
on an independent workstation using the Osiris software.
Because femoral cartilage volume [30], and change in fem-
oral cartilage volume [31] is less reproducible and highly
correlated with tibial cartilage and change in tibial cartilage
volume, tibial cartilage volume was assessed. The volumes
of the individual cartilage plates (medial and lateral tibial)
were measured from the total volume by manually drawing
disarticulation contours around the cartilage boundaries on
each section. The volume of the particular cartilage plate
was determined by summing the pertinent voxels within
the resultant binary volume. A trained observer read each
MRI. Independent measures of volume were made in a
blinded fashion by a second trained observer. The coeffi-
cients of variation for the measurement of cartilage vol-
ume at the medial and lateral tibia were 2.1 % and 2.2 %
respectively [32]. Annual change in volume was calculated
between 2003 and 2004 and 2006 and 2007 using the
following equation: (baseline to follow-up)/time between
scans.
Knee pain
All participants were pain free at the beginning of the
study. At the time of the second MRI they were asked
“have you had any pain in your knee in the past 12 months,
yes or no?” to define incident knee pain, as described
previously [2].
Statistical analyses
Differences between participants in the three groups (i) par-
ticipants with no BMLs, (ii) participants with BMLs visua-
lised using T2-weighted sequence only and (iii) participants
with BMLs visualised using both T1- and T2-weighted
sequences were described using analysis of variance for
continuous variables and chi-square test for dichotomous
variables. Estimated marginal means were used to compare
differences between groups for baseline cartilage volume
and annual percentage change in cartilage, with pairwise
comparisons made using the F test. Where a person had
more than one BML in that compartment, only the largest
BML visualised using T2-weighted images was used. Chi-
Fig. 1 Two BMLs visualised on both T1- and T2-weighted sequences are shown, one on each row. The images on the left, obtained in the sagittal
plane, show the BMLs identified using T1-weighted sequences. The images on the right, obtained in the coronal plane, show the same BMLs imaged
using the T2-weighted sequences. BML bone marrow lesion
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square tests were used to determine any between-group
differences in the frequency of incident knee pain. P
values of less than 0.05 were considered to be statistically
significant. All analyses were performed using the SPSS
statistical package (standard version 20.0, IBM Corp.,
Armonk, NY, USA).
With a sample size of 271, this study had 80 % power
to detect a correlation as low as 0.20 between BMLs and
annual change in cartilage volume (alpha error 0.05,
two-sided significance).
Results and discussion
Comparisons of the participant characteristics according
to the presence of BMLs on T2-weighted images, T1- and
T2-weighted images or absence of BMLs at baseline are
shown in Table 1. A single participant had a BML that
was visualised only on the T1-weighted images in the
medial femoral condyle (characteristics not shown). There
were no significant differences in the baseline characteris-
tics of participants according to their grouping (no BML
present, BMLs visualised on T2-weighted images only and
BMLs visualised on T1- and T2-weighted imaging). Of
the other 296 pain-free participants imaged at baseline,
270 (92 %) completed the study. Apart from those lost to
follow-up having higher BMI (p = 0.01) than those who
completed the study, there were no significant differences
between people who did and did not complete follow-up
(data not shown).
In total, 46 BMLs were seen in 39 participants, with 33
participants having a single BML, five having two BMLs
present and one having three BMLs. Of these, 45 BMLs
(98 %) were visible on images obtained using T2-weighted
sequences, including 34 BMLs (74 %) also visible on T1-
weighted fat-suppressed images. A single BML was visible
on T1-weighted images only. Thus 11 (24 %) were visible
only in T2-weighted images. The sites in which BML were
identified using T2-weighted sequences are shown in
Table 2. Four participants had more than one BML present
in the medial compartment. The volume of BMLs visua-
lised using T1- and T2-weighted sequences are also shown,
as are the ratios between the volumes measured from
T1- and T2-weighted sequences. Whilst BML visualised on
T2-weighted sequences tended to be larger than those
visualised on T1-weighted sequences, this was not universal.
We examined whether cartilage volume and annual
percentage change in cartilage volume at the knee differed
in those individuals without BMLs, compared to those
individuals with BMLs visible on the differently weighted
MRI sequences (Table 3). Of the 271 participants who
completed follow-up, one participant had a BML visua-
lised on T1-weighted images only, 37 participants had
BMLs visualised on T2-weighted images, with 29 (78 %)
also visualised on T1-weighted images. Baseline medial
and lateral cartilage volume was similar in the three
groups, and also after adjusting for baseline age, gender
and BMI. Annual loss of medial tibial cartilage tended to
be different between the three groups (p = 0.07). After
adjusting for age, gender and BMI, annual loss of medial
tibial cartilage was significantly greater in those where a
BML was visualised using T1- and T2-weighted imaging
(45 mm3/annum, standard error of the mean (SEM) 14)
compared to those with BML present in T2-weighted im-
ages only (−13 mm3/annum, SEM 19) and those with no
BML (22 mm3/annum, SEM 3) (p = 0.04). The difference
in cartilage loss in those with a BML seen in T1- and T2-
weighted images compared to those with a BML seen in
T2-weighted images only was significant (57 mm3/annum,
SEM 23, p = 0.01). Annual loss of lateral tibial cartilage
volume was significantly greater in participants where a
BML was visualised on T1- and T2-weighted images
(55 mm3/annum, SEM 3) than when no BML was seen
(22 mm3/annum) (p = 0.01 for difference between these
two groups).
We examined whether the risk of incident knee pain
differed according to the presence of BMLs visualised using
the different sequences at baseline (Table 4). Eighty-five
participants developed knee pain during the study period.
Participants with BML in the medial compartment visua-
lised by both T1- and T2-weighted sequences were more
likely to develop pain than those with no BML at baseline
or a BML visualised using T2-weighted images only (chi-
square, p = 0.04). Those with a BML visualised using both
T1- and T2-weighted sequences were more likely to
develop pain than those with BML visualised only on T2-
weighted images (Fisher’s exact test, p = 0.02) Incident knee
pain was not associated with the presence of BMLs in the
lateral compartment (p = 0.79).
This study examined and characterised clinical and
structural correlates of BMLs identified using two different
Table 1 Baseline participant characteristics according to the
presence of any BML being present1





N = 258 N = 9 N = 29
Age (years) 57.7 (5.2) 59.8 (7.6) 59.9 (6.0) 0.06
Gender, n (%) female 159 (62) 7 (78) 20 (69) 0.483
BMI (kgm−2) 25.7 (4.1) 27.0 (4.0) 27.5 (5.5) 0.09
Baseline tibial cartilage volume (mm3)
Medial 1695 (532) 1609 (382) 1807 (554) 0.49
Lateral 2026 (648) 1994 (724) 2012 (610) 0.98
Results expressed as mean (standard deviation) or number (%)
BML bone marrow lesion, BMI body mass index
1One participant had a BML present only on T1-weighted sequences, and was
not included
2p value expressed as F test – pairwise comparisons among the
unadjusted means
3Chi-square test
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MRI sequences in asymptomatic adults. BMLs visualised
using both T1- and T2-weighted sequences were the most
common. When these were compared to BMLs visualised
only using T2-weighted sequences, they were associated
with greater medial tibial cartilage volume loss and more
frequent incident knee pain over 2 years. This suggests that
using information from multiple MRI sequences to charac-
terise BMLs may provide more prognostic information than
using a single sequence alone.
Different MRI sequences have been developed to identify
and better delineate tissue characteristics and pathologies.
At the knee, when BMLs were initially described, they were
assumed to represent bone oedema [5]. Histological studies
failed to corroborate this, and these abnormalities have
subsequently been referred to BMLs rather than bone
oedema [9, 10]. Sequences deemed to be water sensi-
tive, such as fat-suppressed T2-weighted (FST2w),
proton density-weighted (PDw), intermediate-weighted
Table 2 Site and volume (mm3) of BML according to whether visualised by T2 fat-saturated images only or both T1- and T2-weighted
images
BML seen in T2 only BML seen in T1 and T2
n T2 volume1 n T2 volume1 T1 volume1 % T2 volume2
Medial compartment
Femoral 4 214 (66–543) 12 580 (54–3160) 56 (11–292) 17 % (4–51 %)
Tibial 5 127 (54–328) 6 287(46–616) 163 (14–601) 63 % (5–148 %)
Lateral compartment
Femoral 0 – 8 1407(145–3957) 271 (12–1002) 12 % (6–47 %)
Tibial 2 289 (106–472) 8 530 (89–1604) 107 (14–335) 22 % (9–40 %)
BML bone marrow lesion
1Mean and range of BML volume identified by T2- or T1-weighted sequences, respectively
2BML volume measured from T1-weighted sequences compared to BML volume measured from T2-weighted sequences, expressed as a percentage
Table 3 Relationship between the presence of BML according to sequence at baseline and tibial cartilage volume1
No BML BML in T2 only BML in T1 and T2 p value4
Baseline cartilage volume (mm3)2
Medial compartment
n = 273 n = 7 n = 16
Medial 1705 (32) 1552 (200) 1743 (133) 0.72
Medial, adjusted2 1698 (22) 1722 (139) 1809 (95) 0.52
Lateral compartment
n = 278 n = 2 n = 16
Lateral 2014 (39) 2462 (456) 2176 (161) 0.335
Lateral, adjusted2 2020 (28) 2356 (323) 2137 (117) 0.345
Annual change in cartilage volume (mm3)
Medial compartment
n = 248 n = 7 n = 15
Medial 22 (3) −11 (19) 42 (13) 0.07
Medial, adjusted3 22 (3) −13 (19) 45 (14) 0.04
Lateral compartment
n = 254 n = 2 n = 14
Lateral 22 (3) 70 (36) 55 (13) 0.025
Lateral, adjusted3 22 (3) 69 (36) 55 (14) 0.025
BML bone marrow lesion
1One participant had a BML present only on T1-weighted sequences, and was not included
2Estimated marginal means (standard error of the mean, SEM) used to compare groups adjusted for baseline age, gender, body mass index (BMI)
3Estimated marginal means (SEM) used to compare groups adjusted for baseline age, gender and BMI. Annual change is expressed such that a negative value
represents a gain in cartilage volume
4p value for F test, pairwise comparisons among the estimated marginal means across all groups, except where indicated
5For lateral compartment, the comparison was between those with no BML at baseline and those with BML visible using both T1- and T2-weighted images,
as n = 2 for BML visible using T2-weighted images only
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fat-saturated (IWFS)-fast spin echo (FSE) or STIR, have
been used to determine the presence of BMLs in epidemio-
logical studies, although BMLs are visible using other
sequences such as T1-weighted images [7]. Nevertheless,
these water-sensitive sequences differ in their imaging of
BMLs, with IWFS-FSE and dual-echo steady state (DESS)
imaging sequences having been shown to both identify
BMLs in 65 % of cases, but to be discordant in identifying
BMLs in 36 % of cases [8]. In the current study, we
examined T1- and T2-weighted sequences as described,
and have demonstrated differences in their identification of
BMLs also. These differences may represent variation in
underlying histology of what has been designated a BML
[9]. It has previously been shown that by categorising tissue
according to its imaging characteristics using STIR, T1-
and T2-weighted sequences, differences in tissue histology
could be predicted [9]. That there was no consistent rela-
tionship between the volume of BMLs visualised on the
T1- and T2-weighted sequences used in this study supports
this contention. This variation in the characteristics of the
underlying bone may account for differences in the rela-
tionship between the presence of a BML and subsequent
cartilage loss and clinical disease.
BMLs visualised by both T1- and T2-weighted sequences
were associated with significantly greater cartilage volume
loss compared to knees that had BMLs present only in
T2-weighted images. This is the first study to examine this
question. Previously, we have shown BMLs identified using
T1-weighted images to be associated with an increased risk
of joint replacement [7]. Others have shown BMLs identi-
fied by three-dimensional spoiled gradient-recalled acquisi-
tions with fat suppression [33] or three-dimensional fast
imaging steady state precession acquisitions with water
excitation [6], more closely related to the T2-weighted
images used in the current study, to be predictive of
arthroplasty [6]. Thus it is not possible to compare the
strength of these relationships using the available literature.
Although there was a tendency for those with BMLs
present in T2-weighted images only to show increased
medial tibial cartilage volume, this gain was not significant
(p = 0.07). It is important to consider this in context, as this
cohort was initially pain free and did not have clinical OA.
In animal models, one of the first changes observed in
cartilage is swelling [34]. It is possible that in this initially
asymptomatic cohort, BMLs apparent on T2-weighted
images only identified people at risk for early cartilage
damage, with cartilage swelling. Whether the results that
have shown BMLs visualised using T2-weighted sequences
to be associated with clinical endpoints including knee pain
[35, 36], cartilage loss [24, 29, 37, 38], radiographic progres-
sion [5] and knee arthroplasty [6] would be strengthened
by further stratification by the presence of BMLs visualised
using T1-weighted imaging is unknown. At the back, there
is evidence, albeit limited, that Modic type 1 and 2 changes
have different relationships to low back pain, suggesting
that use of multiple sequences may enable better phenotyp-
ing of musculoskeletal conditions [15].
Although this study has demonstrated that BMLs identi-
fied by different MRI-weighted sequencing predict people
at risk for developing accelerated medial tibial cartilage
volume loss and incident knee pain, the mechanism for
this remains unclear. Different components of BMLs de-
tected by different MRI sequences detect varied histology
[9]. This situation is potentially analogous to what has
been described at the lumbar spine. Modic changes, which
are vertebral body marrow and endplate lesions seen on
MRI, have been classified according to their characteristic
appearance on T1 (FSE two-dimensional T1-weighted
sequences) and T2-weighed images (FSE two-dimensional
T2-weighted images) [11], each with different histological
associations. Modic type 1 change histologically represents
bone marrow oedema and inflammation and are strongly
associated with low back pain [12–15, 17] and instability
[14, 16]. Modic type 2 change represents marrow ischae-
mia and the conversion of normal red haemopoietic bone
marrow into yellow fatty marrow [11] and are more
frequent among individuals with degenerative disc disease
[14, 18, 19]. Modic type 3 change is rare and represents
subchondral bone sclerosis and microfracture [20]. Al-
though the current data provide evidence that different
MRI sequencing of BMLs are associated with different
structural and symptom endpoints, how the differences in
BMLs relate to histological features is not fully charac-
terised. What is, however, interesting from the analogy
between BMLs at the knee and Modic type 2 change at the
lumbar spine is that both abnormalities are associated with
deleterious cartilage changes. That is, Modic type 2 change,
which is hyperintense on both the described T1- and T2-
weighted images, is associated with intervertebral disc
degeneration [14, 18, 19], while knee BMLs visualised by
both the studied sequences are more closely associated with
Table 4 Participants who developed pain according to the
presence of baseline BMLs
Number at baseline Pain developed p value1
Medial compartment
No BML 248 76 (31 %) 0.04
BML in T1 1 1 (100 %)2
BML in T2 7 0 (0 %)
BML in T1 and T2 15 8 (54 %)
Lateral compartment
No BML 279 79 (31 %) 0.79
BML in T2 2 1 (50 %)
BML in T1 and T2 16 5 (36 %)
BML bone marrow lesion
1Chi-square test, likelihood ratio
2Data excluded from analysis
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accelerated medial tibial cartilage volume loss than those
seen in only the T2-weighted sequences examined. Al-
though the intervertebral disc comprises fibrocartilage,
while articular cartilage at the knee is hyaline, these
commonalities might suggest a similar underlying patho-
physiology. Histological differences among BMLs detected
by varying MRI sequences may be a key determinant of
why certain lesions predate accelerated cartilage loss and
the development of incident knee pain.
This study has several limitations. We have examined a
large community-based population of adults without diag-
nosed knee OA and thus our results may not be generalis-
able to those with knee OA. However, the structural
changes that we describe occur on a continuum from the
healthy to the diseased knee. As we examined an asymp-
tomatic population at baseline, BMLs were not common,
so that their relatively small numbers gave us limited power
to assess their correlates. Despite this, we were able to
demonstrate significant differences between those with
BMLs visualised only on T2-weighted images and those
with BMLs visualised on both T1- and T2-weighted images.
Examination of a larger population, incorporating people
with knee pain may help to address this issue.
Conclusions
This study examined and characterised BMLs detected by
different MRI-weighted sequences. BMLs visualised from
both T1- and T2-weighted images were most common and
when compared to BMLs seen in only T2-weighted images,
were associated with greater medial tibial cartilage volume
loss and more incident knee pain. Determining the under-
lying histology of BMLs visualised using different sequences
may allow us to use MRI as a proxy for histology, thus
enabling a better understanding of the pathogenesis of OA
and optimise targeting of therapies aimed at treatment and
prevention of knee OA.
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